Search Results

Aaron is currently the Chief Scientific Officer and VP of Protein Engineering. Aaron has a proven track record as a biologics leader as he led teams to discover and develop novel first-in-class

His lab has worked on building large-scale ways of empirically exploring questions in protein biochemistry

Hannes Schihada Following studies in Pharmacy in Regensburg, Germany, I joined the receptor pharmacology I spent 2 1/2 years in his lab and developed novel conformational sensors for these intriguing receptors

focuses on the mechanisms underlying biased signaling at GPCRs, specifically, the role of differential receptor He primarily studies the chemokine receptor CXCR3 as it has three naturally occurring ligands and thus

episode Fiona Marshall got fascinated with GPCRs after attending a lecture on how the beta-adrenergic receptor biology, Fiona published the first description of the cloning and structural requirements of the GABAB receptor

developing a powerful new computational tool for identifying ‘surrogate’ ligands (borrowed from other receptors this expertise to establish a research program that takes orphan GPCRs from ‘locked’, inaccessible receptors

Ph.D. from Department of Pharmacology, University of Washington (1992, mentor Charley Chavkin , sigma receptors Focus on study of drugs and toxins on GPCR (opioid, cannabinoid receptor) and ion channel (K, Ca, TRP

Since 2013, he has been elected Chair of the subcommittee for the Dopamine receptors of the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug Classification

sedative that prolongs exhalation and induces bradycardia—acting through alpha-2 adrenergic, not opioid, receptors investigates how fentanyl and xylazine shut down breathing through different mechanisms—work that blends receptor Listen now and see how one scientist is turning molecules into a mission, bridging the gap between receptor

San Francisco under the guidance of Professor Shaun Coughlin where she worked on the newly discovered protease-activated program is to gain a thorough and mechanistic understanding of processes that control cell signaling by protease-activated receptors (PARs) and the impact on vascular inflammation and cancer progression. Her laboratory is the recognized expert on protease-activated receptors, particularly PAR1, and over

Medicinal chemist leading purinergic GPCR drug discovery at the NIH, focused on adenosine and nucleotide receptors Recipient of major honors including the ACS Smissman Award and the ASPET Goodman and Gilman Award for Drug Receptor The GPCR Masterclass is a live scientific discussion with a leading expert in GPCR pharmacology, receptor

years of experience in GPCR, primarily focused on drug discovery and developing new tools to study this receptor

the Vesicular Monoamine Transporter 2 (VMAT2), Tyrosine Hydroxylase (TH) and Trace Amine Associate Receptor

Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule Welcome Reception

Her work focuses on both sweet and bitter taste receptor GPCRs and her lab established the BitterDB .

identification of RAMPs (solving some CGRP family issues) and the GABA B, carboxylic, and nicotinic acid receptors

Saraf " My research focuses on evaluating and targeting serotonin 1A receptors for therapeutic outcomes

She has done extensive work on the molecular pharmacology of opioid receptors and is currently focusing

The focus of his research is the molecular pharmacology of cannabinoids and cannabinoid receptors.

What learning from “failed” screens can reveal about receptor pharmacology and species selectivity. The moment when bias agonism and receptor trafficking concepts shifted industry standards for functional Awarded patents and a proven record in both target and pathway identification, his drive centers on integrating

career, the recurring theme in Kari’s work has been GPCRs and more specifically Metabotropic Glutamate Receptors

Julia studies the mechanisms of 'biased signaling' at GPCRs, with a specific focus on the chemokine receptor

The majority of my research is concentrated on rhodopsin family with a few works on metabotropic receptor

Today, Antonella has expanded her research to olfactory GPCRs and trace amine receptors.

Laboratory directed by Jean-Charles Schwartz in Paris, where he cloned and characterized dopamine D2 and D3 receptor

Matters Computational models are moving beyond interpretation into real-world prediction of ligand-receptor His team focuses on understanding how ligands modulate receptor function and how those insights can drive

large compound libraries with the goal of finding new chemical matter to probe understudied and orphan receptors

In 2020, he was promoted to a Readership/Professor in Receptor Pharmacology and was elected a Fellow

During the past 2 decades, my research mainly focused on chemokine receptor structure/function relationships

His group studies the unusual signaling mechanisms employed by these atypical 7-transmembrane receptors